Whole body MRI (WB-MRI) is increasingly being used to assess plasma cell disorders (PCDs). The adoption of WB-MRI provides a niche to further incorporate novel imaging technique into assessment of PCDs, streamlining decision making progress in a cost-effective way.
This abstract and the presentation materials are available to members only; a login is required.